Cargando…

S168: PELABRESIB (CPI-0610) MONOTHERAPY IN PATIENTS WITH HIGH-RISK ESSENTIAL THROMBOCYTHEMIA REFRACTORY OR INTOLERANT TO HYDROXYUREA: PRELIMINARY RESULTS FROM MANIFEST STUDY

Detalles Bibliográficos
Autores principales:	Passamonti, Francesco, Patriarca, Andrea, Knapper, Steven, Rivera, Candido, Scandura, Joseph M, Devos, Timothy, Granacher, Nikki, Mead, Adam, Oh, Stephen, Palmer, Jeanne, Rampal, Raajit K, Teichmann, Lino, LI, Qing, Eliane, Jean-Pierre, Chang, Tzuu-Wang, Klein, Sandra, Colak, Gozde, Harrison, Claire
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Oral Sessions
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428431/ http://dx.doi.org/10.1097/01.HS9.0000967584.99278.43

Ejemplares similares